Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.24M Hold
18,000
0.19% 37
2025
Q1
$813K Hold
18,000
0.15% 44
2024
Q4
$1.1M Hold
18,000
0.18% 35
2024
Q3
$735K Hold
18,000
0.12% 54
2024
Q2
$544K Sell
18,000
-170,000
-90% -$5.45M 0.1% 72
2024
Q1
$7M Hold
188,000
1.91% 12
2023
Q4
$9.24M Sell
188,000
-33,000
-15% -$954K 3.94% 7
2023
Q3
$4.7M Hold
221,000
2.54% 8
2023
Q2
$3.39M Hold
221,000
1.9% 10
2023
Q1
$2.49M Buy
221,000
+100,000
+83% +$1.26M 2.06% 9
2022
Q4
$1.17M Hold
121,000
1.25% 10
2022
Q3
$2.27M Buy
121,000
+21,000
+21% +$549K 2.68% 8
2022
Q2
$1.81M Buy
+100,000
New +$2.72M 2.19% 8

Other funds holding AFRM

Belmont Capital's AFRM Position: Q2 2025 in Review

Belmont Capital held its Affirm (AFRM) position steady in Q2 2025 at 18,000 shares worth $1.24M. The position accounts for 0.19% of the portfolio, ranked #37.

Belmont Capital first reported a position in AFRM in Q2 2022 and has held it in 13 quarters since. The position peaked at $9.24M in Q4 2023. 561 funds tracked by Wall St. Rank hold AFRM as of Q2 2025.

  • Belmont Capital held 18,000 shares of Affirm worth $1.24M as of Q2 2025.
  • Belmont Capital left its Affirm share count unchanged in Q2 2025.
  • Affirm made up 0.19% of Belmont Capital's portfolio in Q2 2025, its #37 holding.
  • Belmont Capital first reported a position in Affirm in Q2 2022 and has held it in 13 quarters since.
  • Belmont Capital's Affirm position peaked at $9.24M in Q4 2023.
  • 561 funds tracked by Wall St. Rank held Affirm as of Q2 2025.

Based on Belmont Capital's 13F filing for Q2 2025, filed 12 Aug 2025.